HIV Infections
Research News and Information

Saturday, November 21, 2009

Transmission of drug-resistant HIV-1 is stabilizing in Europe.

13 Nov 2009 The SPREAD Programme investigated prospectively the time trend from September 2002 through December 2005 of transmitted drug resistance (TDR) among 2793 patients in 20 European countries and in Israel with newly diagnosed human immunodeficiency ... Read more...

High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission.

13 Nov 2009 Given the central role that interleukin 15 (IL-15) plays in human immunodeficiency virus (HIV) immunity, we hypothesized that IL-15 in breast milk may protect against postnatal HIV transmission. In a nested case-control study, we compared breast ... Read more...

Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.

13 Nov 2009 BACKGROUND: The association between postnatal human immunodeficiency virus type 1 (HIV-1) transmission and maternal highly active antiretroviral therapy (HAART) after infant extended antiretroviral prophylaxis was assessed. METHODS: A follow-up ... Read more...

Latest indexed articles for 'HIV Infections'

These are the very latest articles for this heading:

• Infection of T lymphocytes in non-Asian patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. 13 Dec 2009
• HIV/AIDS and diabetes: minimizing risk, optimizing care. 29 Nov 2009
• Microbicide development: positive women's concerns. 29 Nov 2009
• Making the most of your medical visits. 29 Nov 2009
• AIDS vaccine research and advocacy: an update. 29 Nov 2009
• Nanotechnology for antiretroviral drug delivery. 29 Nov 2009
• Transmission of drug-resistant HIV-1 is stabilizing in Europe. 13 Nov 2009
• High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission. 13 Nov 2009
• Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. 13 Nov 2009
• Strategic approaches to decrease breast milk transmission of HIV-1: the importance of small things. 13 Nov 2009
• Impact of amino acid variations in Gag and protease of HIV type 1 CRF01_AE strains on drug susceptibility of virus to protease inhibitors. 30 Oct 2009
• Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression. 30 Oct 2009
• Raltegravir, etravirine, and ritonavir-boosted darunavir: a safe and successful rescue regimen for multidrug-resistant HIV-1 infection. 30 Oct 2009
• Gender differences in discontinuation of antiretroviral treatment regimens. 30 Oct 2009
• Trends in post-infection CD4 cell counts and plasma HIV-1 RNA levels in HIV-1-infected patients in France between 1997 and 2005. 30 Oct 2009
• Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors. 30 Oct 2009
• Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study. 30 Oct 2009
• Molecular characterization of a full-length genome of a HIV-2 isolate from India. 30 Oct 2009
• Prevention of breast milk transmission of HIV: the time is now. 30 Oct 2009
• Frequency of long-term nonprogressors in HIV-1 seroconverters From Rakai Uganda. 30 Oct 2009

See a longer list of these articles.

Technical information about 'HIV Infections'

Definition: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).

Descriptor UI: D015658

Alternative terms: HIV Infections; HIV Infection; Infection, HIV; Infections, HIV; HTLV-III-LAV Infections; HTLV III LAV Infections; HTLV-III-LAV Infection; Infection, HTLV-III-LAV; Infections, HTLV-III-LAV; T-Lymphotropic Virus Type III Infections, Human; T Lymphotropic Virus Type III Infections, Human; HTLV-III Infections; HTLV III Infections; HTLV-III Infection; Infection, HTLV-III; Infections, HTLV-III;

Related Mesh Headings: Lymphoma, AIDS-Related;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; transmission; urine; veterinary; ultrasonography; virology;

Tree Number: C02.782.815.616.400; C02.800.801.400; C20.673.480;

Online Note: use ACQUIRED IMMUNODEFICIENCY SYNDROME to search HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION 1989; HIV INFECTION 1988-89; HTLV-III INFECTION & HTLV-III LAV INFECTION 1987-89

History Note: 90; T-LYMPHOTROPIC VIRUS TYPE III INFECTION, HUMAN was HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION see ACQUIRED IMMUNODEFICIENCY SYNDROME 1989; HIV INFECTION was see ACQUIRED IMMUNODEFICIENCY SYNDROME 1988-89; HTLV-III INFECTION & HTLV-III-LAV INFECTION were see ACQUIRED IMMUNODEFICIENCY SYNDROME 1987-89

Technical Notes: caused by a lentivirus; GEN or unspecified; coord IM with HIV-1 (IM) or HIV-2 (IM); note specific indentions under HIV INFECTIONS; DF: HIV INFECT